When healthcare innovation drives you, the possibilities are endless. Like many successful healthtech entrepreneurs, Gordon Saul has worn many hats throughout his career, experiencing the industry from many different angles. Today, he is an integral part of an incredibly talented team as executive director at Stanford Byers Center for Biodesign, an organization that we are honored to have been partnering and collaborating with for many years.
The growing size and influence of the much-anticipated 38th Annual J.P. Morgan Healthcare Conference continues to drive high attendance and concurrent events. This year, the Fogarty Institute played a larger role by hosting its first Innovator’s reception in partnership with Stanford Biodesign, The MedTech Strategist, RCT and the MedTech Innovator.
The reception was a success,
As a healthcare organization that is deeply invested in the well-being of its patients, El Camino Health has always strived to be at the forefront of innovation. Therefore, it is not surprising that it is also one of the few community hospitals that boasts a dedicated clinical research program. The effort started informally through the work of its physicians and has since evolved into a fully integrated part of the hospital operations as the Taft Center for Clinical Research.
With a goal of helping bring together investors and collaborators in the global medtech industry and shine a light on continuing education, the Fogarty Institute once again participated in the prestigious MedTech Strategist Innovation Summit San Francisco 2019 on November 18 and 19; this year assuming a larger role as a co-sponsor and co-organizer. As in the past,
One of Dr. Fogarty’s strengths when forming new companies was a focus on hiring experts in the field who had the ability to both embrace and expand on his vision. Such was the case when he asked Gary Kalbach to help him start the Fogarty Institute for Innovation in 2007. He became founding president and chair of the board,
“I don’t believe in the concept of the ‘lone genius’ that journalists like to highlight when writing about the success of a company – it’s really the teams that win.”
This year’s 21stAnnual Thomas J. Fogarty, MD, Lecture held at Stanford University, featured Brook Byers, founding partner of Kleiner Perkins.
Edwards Lifesciences’ first and only chairman and CEO, Mike Mussallem, is the leading force behind the company’s success and committed culture of giving back to global communities.
Widely recognized as being at the forefront of patient-focused medical innovations for structural heart disease and critical care monitoring, the company has seen its value jump 4,000 percent and employment double to more than 13,000 in the past 18 years,
The Fogarty Institute has long enjoyed a reciprocal and collaborative relationship with El Camino Health, and over the years we have benefited from the expertise and mentoring of not only its physicians, but also its executive team.
Recently, Jim Griffith, who joined El Camino Hospital as chief operating officer in 2018,
A surgeon, an educator and a physician entrepreneur, James Wall, MD, has already accomplished more than most in his budding career. Recently named co-director of Stanford Biodesign’s Innovation Fellowship, he is an assistant professor of surgery at Stanford University where he focuses on minimally invasive approaches to children’s surgery. He has developed multiple medical devices,
Every industry needs a “voice” standing up for it, and the entrepreneurial sector of the medical device industry is fortunate to have Mark Leahey, president and CEO of the Medical Device Manufacturers Association (MDMA), as its advocate on Capitol Hill.
Mark has spearheaded MDMA since 2001, when the organization was just him,